Introduction {#Sec1}
============

Quantitative cardiovascular magnetic resonance (CMR) is able to provide a wealth of information to help distinguish health from disease. In addition to defining chamber sizes and function, CMR can also determine regional function of the heart as well as tissue composition (myocardial T1 and T2\* relaxation time). Advantages of quantitative evaluation are objective differentiation between pathology and normal conditions, grading of disease severity, monitoring changes under therapy and evaluating prognosis.

Knowledge of normal values is required to interpret the disease state. Thus, the aim of this review is to provide normal reference values for morphological and functional CMR parameters of the cardiovascular system based on a systematic review of the literature using current CMR techniques and sequences. Technical factors such as sequence parameters are relevant for CMR, and these factors are provided as in relationship to the normal values. In addition, factors related to post processing will affect the CMR analysis, and these factors are also described. When multiple peer-reviewed manuscripts are available for normal values, we describe the criteria used to select data for inclusion into this review. When feasible, we provide weighted means based on these literature values. Finally, demographic factors (e.g. age, gender, and ethnicity) may have an influence on normal values and are specified in the review.

Statistical analysis {#Sec2}
====================

Results from multiple studies reporting normal values for the same CMR parameters were combined using a random effects meta-analysis model as implemented by the metan command \[[@CR1]\]. This produced a weighted, pooled estimate of the population mean of the CMR parameters in the combined studies. Upper and lower limits were calculated as ±2SDp, where SD~p~ is the pooled standard deviation calculated from the standard deviations reported in each study \[[@CR2]\]. Statistical analyses were performed with the Stata software package (version 13.1, StataCorp, College Station, TX).

Left ventricular dimensions and functions in the adult {#Sec3}
======================================================

CMR acquisition parameters {#Sec4}
--------------------------

The primary method used to assess the left ventricle is steady state free precession (SSFP) technique at 1.5 Tesla. Steady-state free precession (SSFP) technique yields significantly improved blood-myocardium contrast compared to conventional fast gradient echo (FGRE). However, at 3 Tesla, fast gradient echo CMR may also be used. To date however, no studies have presented normal data at 3 Tesla. The derived cardiac volumes and ventricular mass are known to differ for SSFP and FGRE CMR, so that normal ranges are different for each method \[[@CR3]\].

Publications presenting reference values of the left ventricle based on the SSFP technique are listed in Table [1](#Tab1){ref-type="table"}.Table 1**References, normal LV function and dimensions, SSFP technique, axial imagingFirst author, yearCMR techniqueN, male: femaleAge range (yrs)**Alfakih, 2003 \[[@CR3]\]Short axis SSFP, papillary muscle included in LV mass30:3020-65Hudsmith, 2005 \[[@CR4]\]Short axis SSFP, papillary muscle included in LV mass63:4521-68Maceira, 2006 \[[@CR5]\]Short axis SSFP, papillary muscle included in LV mass60:6020-80SSFP = steady-state free precession; LV = left ventricle; yrs = years.

CMR analysis methods {#Sec5}
--------------------

*Papillary muscle mass* has been shown to significantly affect LV volumes and mass \[[@CR6]\]. No uniformly accepted convention has been used for analyzing trabeculation and papillary muscle mass \[[@CR7]\]. Papillary muscle mass has been noted to account for approximately 9% of total LV mass using FGRE technique \[[@CR6]\]. Thus, tables of normal values should specify the status of the papillary muscles in the CMR analysis. Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"} provide normal values based on papillary muscle mass added to the remainder of the myocardial mass.Table 2**Left ventricular parameters, ages 20--80MenWomenmean** ~**p**~**SD** ~**p**~**Lower/ upper limits\*mean** ~**p**~**SD** ~**p**~**Lower/ upper limits\***EDV \[ml\]16027106-2141322386-178EDV /BSA \[ml/m^2^\]811257-105761056-96ESV \[ml\]541426-82441122-66ESV/BSA \[ml/m^2^\]\*\*26614-3824514-34SV \[ml\]1081872-144871557-117SV/BSA \[ml/m^2^\]\*\*54642-6652738-66EF \[%\]67557-7767557-77Mass \[g\]1342192-176982156-140Mass/BSA \[g/m^2^\]67949-85611041-81LV papillary muscle mass *included as part of LV mass*. Pooled weighted mean values from references \[[@CR3]-[@CR5]\]. Mean~p~ = pooled weighted mean; SD~p~ = pooled standard deviation; \* = calculated as mean~p~ ± 2\*SD~p~; EDV = end-diastolic volume; ESV = end-systolic volume; SV = stroke volume; EF = ejection fraction; BSA = body surface area; SD = standard deviation; \*\*from references \[[@CR4],[@CR5]\] only.Table 3**Left ventricular parameters, by age and gender \[mean ± SD (lower, upper limits\*)\]MenWomenParameter\<60 years≥60 years\<60 years≥60 years**EDV \[ml\]161 ± 21 (119, 203)148 ± 21 (106, 190)132 ± 21 (90, 174)120 ± 21 (78, 162)EDV /BSA \[ml/m^2^\]82 ± 9 (64, 100)76 ± 9 (58, 94)78 ± 8.7 (61, 95)69 ± 8.7 (52, 86)ESV \[ml\]55 ± 11 (33, 77)48 ± 11 (26, 70)44 ± 9.5 (25, 63)38 ± 9.5 (19, 57)ESV/BSA \[ml/m^2^\]28 ± 5.5 (17, 39)25 ± 5.5 (14, 36)26 ± 4.7 (17, 35)22 ± 4.7 (13, 31)SV \[ml\]106 ± 14 (78, 134)100 ± 14 (72, 128)88 ± 14 (60, 116)82 ± 14 (54, 110)SV/BSA \[ml/m^2^\]55 ± 6.1 (43, 67)52 ± 6.1 (40, 64)52 ± 6.2 (40, 64)47.5 ± 6.2 (35, 60)EF \[%\]66 ± 4.5 (57, 75)68 ± 4.5 (59, 77)67 ± 4.6 (58, 76)69 ± 4.6 (60, 78)Mass \[g\]147 ± 20 (107, 187)145 ± 20 (105, 185)106 ± 18 (70, 142)110 ± 18 (74, 146)Mass/BSA \[g/m^2^\]74 ± 8.5 (57, 91)73 ± 8.5 (56, 90)62 ± 7.5 (47, 77)63 ± 7.5 (48, 78)LV papillary muscle mass *included as part of LV mass*. From reference \[[@CR5]\].\* = calculated as mean ±2\*SD; EDV = end-diastolic volume; ESV = end-systolic volume; SV = stroke volume; EF = ejection fraction; BSA = body surface area; SD = standard deviation.

The majority of software approaches use a combination of semi-automated feature recognition combined with manual correction of contours. Short-axis images are most commonly analyzed on a per-slice bases by applying the Simpson's method ("stack of disks") \[[@CR8]\]. An example of left ventricular contouring is shown in Figure [1](#Fig1){ref-type="fig"}.Figure 1**LV contouring.** Note that LV papillary muscle mass has been isolated and added to left ventricular mass.

Demographic parameters {#Sec6}
----------------------

Gender has been demonstrated to have significant independent influence on ventricular volumes and mass. All absolute and normalized volumes decrease in relationship to age in adults \[[@CR5]\] in a continuous manner. When considering younger (e.g. \<65 years) versus older adults (≥65 years), most studies have shown significant differences in normal values for mass and volumes. For convenience, both average, and younger/ older normal values are given in the tables as available in the literature. An age-related normal value may be useful for patients who are at the upper or lower limits of the values in Tables [2](#Tab2){ref-type="table"} and [4](#Tab4){ref-type="table"}.Table 4**Functional and geometric parameters of the normal left ventricle in the adult, from reference** \[[@CR5]\]**MenWomen**PFRE \[ml/s\]527 ± 140 (253, 802)477 ± 146 (190, 764)PFRE /BSA \[ml/m^2^\]270 ± 70 (134, 407)279 ± 81 (121, 437)PFRE/EDV \[/s\]3.4 ± 0.71 (2.0, 4.8)3.8 ± 0.83 (2.1, 5.4)PFRA \[ml/s\]373 ± 82 (212, 534)283 ± 69 (149, 418)PFRA/BSA \[ml/m^2^\]193 ± 44 (107, 279)168 ± 44 (82, 254)PFRA/EDV \[/s\]2.6 ± 0.57 (1.5, 3.7)2.3 ± 0.49 (1.4, 3.3)PFRE/PFRA1.4 ± 0.34 (0.7, 2.8)1.7 ± 0.29 (0.9, 3.1)Septal AVPD \[mm\]15 ± 3.6 (8, 22)14 ± 3.2 (8, 21)Septal AVPD /long length \[%\]15 ± 2.9 (9, 21)16 ± 3.5 (9, 23)Lateral AVPD \[mm\]18 ± 4.1 (9, 26)17 ± 3.2 (11, 24)Lateral AVPD /long length \[%\]17 ± 3.2 (11, 23)19 ± 3.1 (13, 24)Sphericity index, diastole0.35 ± 0.06 (0.22, 0.48)0.4 ± 0.07 (0.27, 0.53)Sphericity index, systole0.20 ± 0.05 (0.10, 0.29)0.23 ± 0.068 (0.09, 0.36)Means ± standard deviation and (95% confidence intervals) are given.BSA = body surface area; PFR = peak filling rate; E = early; A = active; AVPD = atrioventricular plane descent.

Studies included in this review {#Sec7}
-------------------------------

Multiple studies have presented cohorts of normal individuals for determining normal dimensions of the left ventricle. For the purpose of this review, only cohorts of 30 or more normal subjects by gender using SSFP CMR have been included. Only data at 1.5T is available for normal subjects using SSFP short axis imaging. Inclusion criteria for the tables below also included a full description of the subject cohort (including the analysis methods used), age and gender of subjects. One study used SSFP radial imaging, and is not included in this review \[[@CR9]\].

Multiple studies (not shown in the tables) have used FGRE technique at 1.5T \[[@CR9]-[@CR13]\]. While FGRE is currently used at 3T in some settings, the relevance of FGRE technique at 1.5T to that at 3T is not known.

Because slice FGRE acquisition parameters at 3T are different than at 1.5T, adaptation of 1.5T FGRE normal parameters to 3T FGRE imaging is not recommended. Information on ethnicity in relationship to LV parameters is not available for SSFP technique. Finally, the studies in Table [1](#Tab1){ref-type="table"} were all conducted in European centers. Normal values for left ventricular dimensions and functions according to these studies are presented in Tables [2](#Tab2){ref-type="table"}, [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"}. Age dependent normal values for men and women are also presented in Figures [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}.Figure 2**Left ventricular volumes, mass and function in systole and diastole normalized to age and body surface area for males according to reference \[** [@CR5] **\].**Figure 3**Left ventricular volumes, mass and function in systole and diastole normalized to age and body surface area for females according to reference \[** [@CR5] **\].**

Additional LV function parameters {#Sec8}
---------------------------------

In addition to ejection fraction, Maceira et al. have provided additional functional parameters that may be useful in some settings \[[@CR5]\]. For diastolic function, the derivative of the time/ volume filling curve expresses the peak filling rate (PFR). Both early (E) and active (A) filling rates are provided. In addition, longitudinal atrioventricular plane descent (AVPD) and sphericity index (volume observed/volume of sphere using long axis as diameter) at end diastole and end systole are given. These latter parameters are not routinely used for clinical diagnosis.

Right ventricular dimensions and functions in the adult {#Sec9}
=======================================================

CMR acquisition parameters {#Sec10}
--------------------------

For measurement of right ventricular volumes a stack of cine SSFP images acquired either horizontally or in short axis view can be used \[[@CR7]\].

CMR analysis methods {#Sec11}
--------------------

Similar to the left ventricle, analysis of the right ventricle is usually performed on a per slice basis by manual contouring of the endocardial and epicardial borders. Volumes are calculated based on the Simpson's method \[[@CR8]\]. The right ventricular volumes and mass are significantly affected by inclusion or exclusion of trabeculations and papillary muscles \[[@CR14],[@CR15]\]. For manual contouring, inclusion of trabeculations and papillary muscles as part of the right ventricular volume will achieve higher reproducibility \[[@CR7],[@CR14],[@CR15]\]. However, semiautomatic software is increasingly used for volumetric analysis, enabling automatic delineation of papillary muscles \[[@CR16]\]. Therefore normal values for both methods are provided. An example of right ventricular contouring using a semiautomatic software is shown in Figure [4](#Fig4){ref-type="fig"}.Figure 4**Example of RV contouring using a semiautomatic software.** Note that papillary muscles were included in RV mass (arrow).

Detailed recommendations for right ventricular acquisitions and post processing have been published \[[@CR7]\].

Demographic parameters {#Sec12}
----------------------

BSA has been shown to have an independent influence on RV mass and volumes \[[@CR16]\]. Absolute and normalized RV volumes are significantly larger in males compared to females \[[@CR3],[@CR4],[@CR16]\]. Further, RV mass and volumes decrease with age \[[@CR4],[@CR16]\].

Studies included in this review {#Sec13}
-------------------------------

Criteria regarding study inclusion are identical compared to the left ventricle. Three studies based on SSFP imaging were included (Table [5](#Tab5){ref-type="table"}). In two studies, trabeculations and papillary muscles were included as part of the right ventricular cavity \[[@CR3],[@CR4]\], and pooled weighted mean values of the two studies are presented in Table [6](#Tab6){ref-type="table"}. In the third study papillary muscles were considered part of the right ventricular mass \[[@CR16]\]. Similar to the left ventricle, data is presented as a younger age (\<60 years) and an older age group (≥60 years) (Table [7](#Tab7){ref-type="table"}). Further, age dependent normal values for men and women are presented in Figures [5](#Fig5){ref-type="fig"} and [6](#Fig6){ref-type="fig"}.Table 5**References, normal right ventricular function and dimensions, SSFP techniqueFirst author, yearCMR techniqueN, male: femaleAge range (yrs)**Alfakih, 2003 \[[@CR3]\]Short axis SSFP, papillary muscles and trabeculation included in RV volume30:3020-65Hudsmith, 2005 \[[@CR4]\]Short axis SSFP, papillary muscles and trabeculation included in RV volume63:4521-68Maceira, 2006 \[[@CR16]\]Short axis SSFP, papillary muscle included in RV mass60:6020-80SSFP = steady-state free precession; RV = right ventricle; yrs = years.Table 6**Right ventricular parameters, ages 20--68MenWomenParametermean** ~**p**~**SD** ~**p**~**Lower/ upper limits\*mean** ~**p**~**SD** ~**p**~**Lower/ upper limits\***EDV \[ml\]18433118-2501393177-201EDV /BSA \[ml/m^2^\]911561-121801648-112ESV \[ml\]791941-117541524-84ESV/BSA \[ml/m^2^\]\*\*391019-59321012-52SV \[ml\]1061968-144841848-120SV/BSA \[ml/m^2^\]\*\*57841-7353935-71EF \[%\]62552-7261551-71Mass \[g\]\*\*41825-5735721-49Mass/BSA \[g/m^2^\]\*\*21413-2920412-28Right ventricular trabeculations and papillary muscle mass *included as part of right ventricular volume*.Pooled weighted mean values from references \[[@CR3],[@CR4]\].mean~p~ = pooled weighted mean; SD~p~ = pooled standard deviation; \* = calculated as mean~p~ ± 2\*SD~p~; EDV = end-diastolic volume; ESV = end-systolic volume; SV = stroke volume; EF = ejection fraction; BSA = body surface area; SD = standard deviation; \*\*from reference \[[@CR4]\] only.Table 7**Right ventricular parameters, by age and gender \[mean ± SD (lower/upper limits\*)\]MenWomenParameter\<60 years≥60 years\<60 years≥60 years**EDV \[ml\]169 ± 25 (119, 219)153 ± 25 (103, 203)133 ± 22 (89, 177)114 ± 22 (70, 158)EDV /BSA \[ml/m^2^\]87 ± 12 (63, 111)77 ± 12 (53, 101)78 ± 9 (60, 96)66 ± 9 (48, 84)ESV \[ml\]62 ± 15 (32, 92)48 ± 15 (18, 78)49 ± 13 (23, 75)35 ± 13 (9, 61)ESV/BSA \[ml/m^2^\]32 ± 7 (18, 46)24 ± 7 (10, 38)28 ± 7 (14, 42)20 ± 7 (6, 34)SV \[ml\]107 ± 17 (73, 141)105 ± 17 (71, 139)85 ± 13 (59, 111)80 ± 13 (54, 106)SV/BSA \[ml/m^2^\]55 ± 8 (39, 71)53 ± 8 (37, 69)50 ± 6 (38, 62)46 ± 6 (34, 58)EF \[%\]64 ± 7 (50, 78)69 ± 7 (55, 83)64 ± 6 (52, 76)70 ± 6 (58, 82)Mass \[g\]68 ± 14 (40, 96)63 ± 14 (35, 91)50 ± 11 (28, 72)44 ± 11 (22, 66)Mass/BSA \[g/m^2^\]35 ± 7 (21, 49)32 ± 7 (18, 46)30 ± 5 (20, 40)25 ± 5 (15, 35)Right ventricular trabeculations and papillary muscle mass *included as part of right ventricular mass.* From reference \[[@CR16]\].EDV = end-diastolic volume; ESV = end-systolic volume; SV = stroke volume; EF = ejection fraction; BSA = body surface area; SD = standard deviation; \* = calculated as mean ± 2\*SD.Figure 5**Right ventricular volumes, mass and function for males by age decile.**Figure 6**Right ventricular volumes, mass and function for females by age decile.**

Additional RV function parameters {#Sec14}
---------------------------------

Similar to the LV, Maceira et al. have provided additional functional parameters \[[@CR16]\] (Table [8](#Tab8){ref-type="table"}) that may have relevance to specific applications.Table 8**Functional and geometric parameters of the normal right ventricle in the adult, from reference** \[[@CR16]\] **\[mean ± SD (95% CI)\]MenWomen**PFRE \[ml/s\]405 ± 137 (137, 674)337 ± 117 (107, 567)PFRE /BSA \[ml/m^2^\]207 ± 70 (68, 345)197 ± 68 (64, 330)PFRE/EDV \[/s\]2.4 ± 0.75 (1.0, 3.9)2.7 ± 0.85 (1.0, 4.3)PFRA \[ml/s\]489 ± 175 (146, 833)368 ± 153 (67, 668)PFRA/BSA \[ml/m^2^\]250 ± 94 (66, 434)215 ± 89 (40, 390)PFRA/EDV \[/s\]3.1 ± 1.0 (1.0, 5.2)2.9 ± 1.0 (0.9, 5.0)PFRE/PFRA0.8 ± 0.49 (−0.1, 1.8)0.9 ± 0.46 (0.0, 1.8)Septal AVPD \[mm\]15 ± 4.1 (6, 23)13 ± 3.0 (7, 19)Septal AVPD /long length \[%\]17 ± 4.5 (8, 26)17 ± 3.9 (9, 25)Lateral AVPD \[mm\]22 ± 4.4 (13, 30)21 ± 3.5 (14, 27)Lateral AVPD /long length \[%\]23 ± 4.1 (15, 31)24 ± 4.0 (16, 32)BSA = body surface area; PFR = peak filling rate; E = early; A = active; AVPD = atrioventricular plane descent; SD = standard deviation; CI = confidence interval.

Left atrial dimensions and functions in the adult {#Sec15}
=================================================

CMR acquisition parameters {#Sec16}
--------------------------

There is limited consensus in the literature about how to measure left atrial volumes. Therefore depending on the method that is used, SSFP sequences in different views are required. The most common methods to measure left atrial volume are the modified Simpson's method analogous to the left and right ventricle and the biplane area-length method. Dedicated 3D-modeling software has also been used \[[@CR17]\]. For evaluation by applying the Simpson's method, a stack of cine SSFP images either in the short axis, the horizontal long axis or transverse view is required. For 3-dimensional modeling a stack of short axis images has been used \[[@CR17]\]. Evaluation by the biplane area-length method is based on a 2 and 4 chamber view \[[@CR4]\].

Left atrial longitudinal and transverse diameters and area have been measured on 2, 3, and 4 chamber cine SSFP images \[[@CR17]\].

CMR analysis methods {#Sec17}
--------------------

Generally the left atrial appendage is included as part of the left atrial volume while the pulmonary veins are excluded \[[@CR4],[@CR17],[@CR18]\].

The maximal left atrial volume is achieved during ventricular systole. Using cine images, the maximum volume can be defined as last image before opening of the mitral valve. Accordingly the minimal left atrial volume can be defined as first image after closure of the mitral valve \[[@CR19]\].

Demographic parameters {#Sec18}
----------------------

Body surface area (BSA) has been shown to have a significant independent influence on left atrial volume and most diameters \[[@CR17]\]. Per Sievers et al. \[[@CR20]\], age is not an independent predictor of left atrial maximal volume \[[@CR17]\] nor diameter in normal individuals. Men have a larger maximal left atrial volume compared to women \[[@CR4],[@CR17]\].

Studies included in this review {#Sec19}
-------------------------------

There are three publications for reference values of the left atrium (volume and/or diameter and/or area) based on SSFP imaging with a sufficient sample size \[[@CR4],[@CR17],[@CR20]\] (Table [9](#Tab9){ref-type="table"}). Hudsmith et al. \[[@CR4]\] used the biplane area-length method (Figure [7](#Fig7){ref-type="fig"}), while Maceira et al. \[[@CR17]\] used a 3D modeling technique (Figure [8](#Fig8){ref-type="fig"}). Since the results for left atrial maximal volume differ substantially between the two publications, probably based on the different methods, these data are presented separately (Tables [10](#Tab10){ref-type="table"} and [11](#Tab11){ref-type="table"}, respectively). Maceira et al. provide reference values for maximum left atrial volume, longitudinal, transverse and anteroposterior diameters as well as area (Tables [11](#Tab11){ref-type="table"}, [12](#Tab12){ref-type="table"} and [13](#Tab13){ref-type="table"}; Figures [8](#Fig8){ref-type="fig"} and [9](#Fig9){ref-type="fig"}) \[[@CR17]\]. Hudsmith evaluated normal values of maximal and minimal left atrial volume and calculated left atrial ejection fraction and left atrial stroke volume (Table [10](#Tab10){ref-type="table"}) \[[@CR4]\]. Sievers et al. provide reference values for left atrial transverse diameters measured on the 2-, 3- and 4-chamber view at ventricular end-systole \[[@CR20]\]. Maceira et al. provide both transverse and longitudinal diameters with different 3-chamber methodology than Sievers et al., thus only diameters of Maceira et al. are included (Table [13](#Tab13){ref-type="table"}) \[[@CR17],[@CR20]\].Table 9References, normal left atrial function and dimensions, SSFP technique**First author, yearCMR techniqueN, male: femaleAge range (yrs)**Sievers, 2005 \[[@CR20]\]2, 3 and 4 chamber SSFP; measurement of diameters59:5225-73Hudsmith, 2005 \[[@CR4]\]2 and 4 chamber SSFP; biplane area-length method; atrial appendage included, pulmonary veins excluded63:4521-68Maceira, 2010 \[[@CR17]\]Short axis, 2, 3 and 4 chamber SSFP; 3D modeling and measurement of area and diameters; atrial appendage included, pulmonary veins excluded (for volume analysis)60:6020-80SSFP = steady-state free precession; yrs = years.Figure 7**Example of contouring for the biplane area-length method from reference \[** [@CR4] **\].** The left atrial appendage was included in the atrial volume and the pulmonary veins were excluded.Figure 8**Contouring of the left and right atrium using a 3D modeling method according to reference \[** [@CR17] **\].**Table 10**Left atrial volume and function in the adult for the SSFP technique based on the biplane area-length method according to reference** \[[@CR4]\]**ParameterMenWomenmeanSDLower/ upper limits\*meanSDLower/ upper limits\***Max. LA volume (ml)1033043-163892147-131Min. LA volume (ml)461418-74411119-63EF (%)551329-8153935-71SV (ml)582312-104481518-78LA = left atrial; Max. = maximal; Min. = minimal; EF = ejection fraction; SV = stroke volume; SD = standard deviation; \* = calculated as mean ± 2\*SD.Table 11**Left atrial maximal volume in the adult for the SSFP technique based on 3D modeling methods, according to reference** \[[@CR17]\]**ParameterMenWomenmeanSDLower/ upper limits\*meanSDLower/ upper limits\***Max. LA volume (ml)7714.947-1076814.938-98Max. LA volume/BSA (ml/m^2^)396.726-52406.727-53LA = left atrial; Max. = maximal; BSA = body surface area; SD = standard deviation; \* = calculated as mean ± 2\*SD.Table 12**Left atrial maximal area in the adult for the SSFP technique, according to reference** \[[@CR17]\]**ParameterMenWomenmeanSDLower/ upper limits\*meanSDLower/ upper limits\***Area (cm^2^) 4ch223.715-29203.713-27Area/BSA (cm^2^/ m^2^) 4ch111.87-15121.88-16Area (cm^2^) 2ch214.712-30194.710-28Area/BSA (cm^2^/ m^2^) 2ch112.46-16112.46-16Area (cm^2^) 3ch193.612-26173.610-24Area/BSA (cm^2^/ m^2^) 3ch101.86-14101.86-14LA = left atrial; BSA = body surface area; SD = standard deviation; \* = calculated as mean ± 2\*SD; 4ch = 4-chamber view; 2ch = 2-chamber view; 3ch = 3-chamber view.Table 13**Left atrial diameter in the adult for the SSFP technique according to reference** \[[@CR17]\]**ParameterMenWomenmeanSDLower/ upper limits\*meanSDLower/ upper limits\***Longitudinal diameter (cm) 4ch5.90.74.5-7.35.50.74.1-6.9Longitudinal diameter/BSA (cm/m^2^) 4ch3.00.42.2-3.83.20.42.4-4.0Transverse diameter (cm) 4ch4.10.53.1-5.14.10.53.1-5.1Transverse diameter/BSA (cm/m^2^) 4ch2.10.31.5-2.72.40.31.8-3.0Longitudinal diameter (cm) 2ch5.00.73.6-6.44.60.73.2-6.0Longitudinal diameter/BSA (cm/m^2^) 2ch2.50.41.7-3.32.70.41.9-3.5Transverse diameter (cm) 2ch4.60.53.6-5.64.40.53.4-5.4Transverse diameter/BSA (cm/m^2^) 2ch2.30.21.9-2.72.60.22.2-3.0AP diameter (cm) 3ch3.30.52.3-4.33.10.52.1-4.1AP diameter/BSA (cm/m^2^) 3ch1.70.31.1-2.31.80.31.2-2.4BSA = body surface area; SD = standard deviation; \* = calculated as mean ± 2\*SD; 4ch = 4-chamber view; 2ch = 2-chamber view; 3ch = 3-chamber view; AP = anteroposterior.Figure 9**Measurement of left atrial area (A2C, A4C, A3C), longitudinal (L2C, L4C), transverse (T2C, T4C) and anteroposterior (APD) diameters on the 2-, 4- and 3-chamber views according to reference \[** [@CR17] **\].**

Right atrial dimensions and functions in the adult {#Sec20}
==================================================

CMR acquisition parameters {#Sec21}
--------------------------

There is no consensus in the literature regarding acquisition and measurement method for the right atrium. Published methods for right atrial volume include the modified Simpson's method, the biplane area-length method and 3D-modeling \[[@CR21],[@CR22]\]. Comparing the Simpsons method and the biplane area length method results in different values for right atrial volume \[[@CR21]\]. For Simpson's method and 3D modeling, a stack of cine SSFP images in the short axis view are analyzed. For the biplane area-length method, a 4-chamber view and/or a right ventricular 2-chamber view are evaluated.

CMR analysis methods {#Sec22}
--------------------

Generally the right atrial appendage is included in the right atrial volume while the inferior and superior vena cava are excluded \[[@CR21],[@CR22]\].

The maximal right atrial volume is achieved during ventricular systole and can be defined as last cine image before opening of the tricuspid valve. The minimal left atrial volume can be defined as first cine image after closure of the tricuspid valve.

Demographic parameters {#Sec23}
----------------------

Maceira et al. demonstrated a significant independent influence of BSA on most RA parameters \[[@CR22]\]. There was no influence of age on atrial parameters and no influence of gender on atrial volumes \[[@CR21],[@CR22]\].

Studies included in this review {#Sec24}
-------------------------------

There are two publications of reference values for the right atrium (volume and/or diameter) based on SSFP imaging with a sufficient sample size \[[@CR21],[@CR22]\] (Table [14](#Tab14){ref-type="table"}). For evaluation of volume, Maceira et al. \[[@CR22]\] used a 3D modeling technique (Figure [8](#Fig8){ref-type="fig"}) while Sievers et al. \[[@CR21]\] applied the Simpsons and the biplane area-length methods, respectively. Due to different methodology, no pooled mean values are provided. Normal values for right atrial volume and function, diameter and area are presented in Tables [15](#Tab15){ref-type="table"}, [16](#Tab16){ref-type="table"}, [17](#Tab17){ref-type="table"}, [18](#Tab18){ref-type="table"} and [19](#Tab19){ref-type="table"}.Table 14**References, normal RA function and dimensions, SSFP techniqueFirst author, yearCMR techniqueN, male: femaleAge range (yrs)**Sievers, 2007 \[[@CR21]\]Short axis SSFP and 4 chamber SSFP; Simpsons method and biplane area length method; atrial appendage included, pulmonary veins excluded38:3225-73Maceira, 2013 \[[@CR22]\]Short axis SSFP; 3D modeling; atrial appendage included, pulmonary veins excluded60:6020-80SSFP = steady-state free precession; yrs = years.Table 15**Right atrial volume and function in the adult for the SSFP technique based on the Simpson's method according to reference** \[[@CR21]\]**ParametermeanSDLower/ upper limits\***Max. RA volume (ml)1013041-161Max. RA volume/BSA (ml/ m^2^)531621-85Min. RA volume (ml)501912-88Min. RA volume/BSA (ml/m^2^)27107-47SV (ml)501618-82SV/BSA (ml/m^2^)2698-44EF (%)47831-63RA = right atrial; Max. = maximal; Min. = minimal; SV = stroke volume; EF = ejection fraction; SD = standard deviation; BSA = body surface area; \* = calculated as mean ± 2\*SD; since no influence of gender was demonstrated, gender specific values are not presented.Table 16**Right atrial volume and function in the adult for the SSFP technique based on the biplane-area-length method according to reference** \[[@CR21]\]**ParametermeanSDLower/ upper limits\***Max. RA volume (ml)1033337-169Max. RA volume/BSA (ml/ m^2^)541818-90Min. RA volume (ml)512011-91Min. RA volume/BSA (ml/m^2^)27115-49SV (ml)521718-86SV/BSA (ml/m^2^)2799-45EF (%)51933-69RA = left atrial; Max. = maximal; Min. = minimal; SV = stroke volume; EF = ejection fraction; SD = standard deviation; BSA = body surface area; \* = calculated as mean ± 2\*SD; since no influence of gender was demonstrated, gender specific values are not presented.Table 17**Right atrial volume in the adult for the SSFP technique based a 3D modeling technique according to reference** \[[@CR22]\]**ParametermeanSDLower/ upper limits\***Max. RA volume (ml)1002060-140Max. RA volume/BSA (ml/ m^2^)541034-74RA = left atrial; Max. = maximal; \* = calculated as mean ± 2\*SD; BSA = body surface area; since no influence of gender was demonstrated, gender specific values are not presented.Table 18**Right atrial maximal area in the adult for the SSFP technique according to reference** \[[@CR22]\]**ParametermeanSDLower/ upper limits\***Area (cm^2^) 4ch223.814-30Area/BSA (cm^2^/ m^2^) 4ch121.88-16Area (cm^2^) 2ch223.9514-30Area/BSA (cm^2^/ m^2^) 2ch122.277-17BSA = body surface area; \* = calculated as mean ± 2\*SD; since no influence of gender was demonstrated, gender specific values are not presented.Table 19**Right atrial diameter in the adult for the SSFP technique according to reference** \[[@CR22]\]**ParametermeanSDLower/ upper limits\***Longitudinal diameter (cm) 4ch5.50.584.3-6.7Longitudinal diameter/BSA (cm/m^2^) 4ch3.00.322.4-3.6Transverse diameter (cm) 4ch4.70.553.6-5.8Transverse diameter/BSA (cm/m^2^) 4ch2.60.32.0-3.2Longitudinal diameter (cm) 2ch5.40.54.4-6.4Longitudinal diameter/BSA (cm/m^2^) 2ch2.90.32.3-3.5Transverse diameter (cm) 2ch4.30.72.9-5.7Transverse diameter/BSA (cm/m^2^) 2ch2.40.41.6-3.2BSA = body surface area; SD = standard deviation; \* = calculated as mean ± 2\*SD; 4ch = 4-chamber view; 2ch = 2-chamber view; since no influence of gender was demonstrated, gender specific values are not presented.

Left and right ventricular dimensions and function in children {#Sec25}
==============================================================

The presentation of normal values in children is different than in the adult population due to continuous changes in body weight and height as a function of age. These changes may also be asymmetrical. Normal data in children is frequently presented in percentiles and/or z-scores. While the use of percentiles is a daily routine for the paediatric radiologist, the use of percentile data might be unfamiliar to the general radiologist. Therefore in the current review, normal values are presented as mean ± standard deviation as well as in percentiles.

Demographic parameters {#Sec26}
----------------------

A linear correlation between ventricular volumes and BSA in children has been reported. Ventricular volumes also vary by gender \[[@CR23]-[@CR25]\]. Ejection fraction remains constant during somatic growth and does not appear to be gender specific \[[@CR23]-[@CR25]\]. Gender differences are more marked in older children, indicating that gender is more important after puberty and in adulthood.

Studies included in this review {#Sec27}
-------------------------------

Normal values published in studies based on older gradient echo sequences are not comparable to current SSFP techniques \[[@CR26],[@CR27]\]. Literature values for normative SSFP values have been proposed by three different groups acquired with slightly different methods \[[@CR23]-[@CR25]\] (Table [20](#Tab20){ref-type="table"}). A good agreement between the three studies regarding the dimensions for older children has been demonstrated \[[@CR25]\].Table 20**References, normal left and right ventricular dimensions in childrenFirst author, yearCMR techniqueN, male: femaleAge range (yrs)**Robbers-Visser, 2009 \[[@CR23]\]Short axis SSFP, papillary muscle/ trabeculation excluded from volumes30:30\*8-17Buechel, 2009 \[[@CR25]\]Short axis SSFP, papillary muscle/trabeculation included in volumes, separate analysis of papillary muscle mass23:27\*\*7 mo -- 18Sarikouch, 2010 \[[@CR24]\]Axial SSFP (in 29 children additional short axis stack), papillary muscle/ trabeculation excluded from volumesTotal: 55:59\* Percentiles: 51:48Total: 4--20 Percentiles: 8-20SSFP = steady-state free precession; yrs = years; mo = month; \* = none of the subjects was sedated; \*\* = 13 subjects were sedated.

In the studies of Robbers-Visser et al. and Sarikouch et al., normal values for older children of 8--17 years and 4--20 years, respectively, are presented \[[@CR23],[@CR24]\], Buechel et al. also include younger children starting with an age of 7 months. In the studies of Robbers-Visser et al. and Sarikouch et al. papillary muscle mass was included as part of LV mass, while Buchel et al. included papillary muscles in the LV cavity and provide separate values for papillary muscle mass. Robbers-Visser et al. and Sarikouch et al. present normal values as mean ± SD for all female and male children and for children of different age groups and also as percentiles. In the study by Buechel et al. data is presented in percentiles only.

Due to similar study design and age range, Tables [21](#Tab21){ref-type="table"} and [22](#Tab22){ref-type="table"} show pooled mean values for male and female children calculated based on mean values presented by Robbers-Visser et al. and Sarikouch et al. Figures [10](#Fig10){ref-type="fig"},[11](#Fig11){ref-type="fig"},[12](#Fig12){ref-type="fig"} show normal data in percentiles originally published by Buechel et al.Table 21**Left ventricular parameters in children, ages 8--17ParameterMaleFemalemean** ~**p**~**SD** ~**p**~**Lower/ upper limits\*mean** ~**p**~**SD** ~**p**~**Lower/ upper limits\***EDV/BSA \[ml/m^2^\]801256-104751055-95ESV/BSA \[ml/m^2^\]28616-4025515-35SV/BSA \[ml/m^2^\]\*\*54936-7250834-66EF \[%\]\*\*66556-7663651-75CI \[l/min/ m^2^\]\*\*4.40.852.7-6.13.90.622.7-5.1Mass/BSA \[g/m^2^\]621238-8653935-71Left ventricular papillary muscle mass included as part of left ventricular mass. Pooled weighted mean values from references \[[@CR23],[@CR24]\].mean~p~ = pooled weighted mean; SD~p~ = pooled standard deviation; \* = calculated as mean~p~ ± 2\*SD~p~; EDV = end-diastolic volume; ESV = end-systolic volume; BSA = body surface area; SV = stroke volume; EF = ejection fraction; CI = cardiac index; SD = standard deviation; \*\* = from reference \[[@CR24]\] (8--15 years) only.Table 22**Right ventricular parameters in children, ages 8--17ParameterMaleFemalemean** ~**p**~**SD** ~**p**~**Lower/ upper limits\*mean** ~**p**~**SD** ~**p**~**Lower/ upper limits\***EDV/BSA \[ml/m^2^\]841260-10876958-94ESV/BSA \[ml/m^2^\]32718-4627517-37SV/BSA \[ml/m^2^\]\*\*52836-6849735-63EF \[%\]\*\*62454-7063455-71Mass/BSA \[g/m^2^\]21511-3118410-26Right ventricular trabeculation included as part of right ventricular mass. Pooled weighted mean values from references \[[@CR23],[@CR24]\].mean~p~ = pooled weighted mean; SD~p~ = pooled standard deviation; \* = calculated as mean~p~ ± 2\*SD~p~ EDV = end-diastolic volume; ESV = end-systolic volume; BSA = body surface area; SV = stroke volume; EF = ejection fraction; SD = standard deviation; \*\* = from reference \[[@CR24]\] only.Figure 10**Percentiles for left ventricular parameters in children according to reference \[** [@CR25] **\].**Figure 11**Percentiles for left ventricular papillary muscle mass in children according to reference \[** [@CR25] **\].**Figure 12**Percentiles for right ventricular parameters in children according to reference \[** [@CR25] **\].**

Z-values can be calculated as z-value = (measurement -- expected mean)/SD by using the values presented in Tables [21](#Tab21){ref-type="table"} and [22](#Tab22){ref-type="table"}.

Left and right atrial dimensions and function in children {#Sec28}
=========================================================

CMR acquisition parameters {#Sec29}
--------------------------

Left and right atrial dimensions and function were evaluated using SSFP technique in a single publication \[[@CR18]\], (Table [23](#Tab23){ref-type="table"}). Measurements were obtained on a stack of transverse cine SSFP images with a slice thickness between 5 and 6 mm without interslice gap \[[@CR18]\].Table 23**Reference, normal left and right atrial dimensions in childrenFirst author, yearCMR techniqueN, male: femaleAge range (yrs)**Sarikouch, 2011 \[[@CR18]\]Axial SSFP; pulmonary veins, SVC, IVC and coronary sinus excluded, atrial appendages included from/in the left and right atrial volume, respectively56:594.4-20.3SSFP = steady-state free precession; SVC = superior vena cava; IVC inferior vena cava; yrs = years.

CMR analysis methods {#Sec30}
--------------------

In that study, the pulmonary veins, the superior and inferior vena cava and the coronary sinus were excluded from the left and right atrial volume, respectively, while the atrial appendages were included in the volume of the respective atrium. The maximal atrial volume was measured at ventricular end-systole and the minimal atrial volume at ventricular end-diastole.

Demographic parameters {#Sec31}
----------------------

Left and right atrial volumes show an increase with age with a plateau after the age of 14 for girls only. Absolute and indexed volumes have been shown to be significantly greater for boys compared to girls (except for the indexed maximal volumes for both atria) \[[@CR18]\].

Studies included in this review {#Sec32}
-------------------------------

Sarikouch et al. evaluated atrial parameters of 115 healthy children (Table [23](#Tab23){ref-type="table"}) \[[@CR18]\] using SSFP imaging. Since the standard deviation is large for each parameter, lower and upper limits were not calculated (Tables [24](#Tab24){ref-type="table"} and [25](#Tab25){ref-type="table"}). Theoretically calculation of lower limits by mean -- (2\*SD) would result in negative lower limits for certain parameters.Table 24**Left atrial parameters in children, ages 4--20 according to reference** \[[@CR18]\]**MaleFemaleParametermeanSDmeanSD**Vol. max. \[ml\]71305920Vol. max./BSA \[ml/m^2^\]4710449Vol. min. \[ml\]3315269Vol. min./BSA \[ml/m^2^\]225194SV \[ml\]38163312EF \[%\]546566Vol. max. = maximal atrial volume; Vol. min. = minimal atrial volume; BSA = body surface area; SV = stroke volume; EF = ejection fraction; SD = standard deviation.Table 25**Right atrial parameters in children, ages 4--20 according to reference** \[[@CR18]\]**MaleFemaleParametermeanSDmeanSD**Vol. max. \[ml\]89437125Vol. max./BSA \[ml/m^2^\]58165312Vol. min. \[ml\]42213113Vol. min./BSA \[ml/m^2^\]278236SV \[ml\]47244015EF \[%\]537568Vol. max. = maximal atrial volume; Vol. min. = minimal atrial volume; BSA = body surface area; SV = stroke volume; EF = ejection fraction; SD = standard deviation.

Normal left ventricular myocardial thickness {#Sec33}
============================================

CMR acquisition parameters {#Sec34}
--------------------------

Normal values of left ventricular myocardial thickness (LVMT) have been shown to vary by type of pulse sequence (FGRE versus SSFP) \[[@CR3],[@CR28]\]. For the purposes of this review, only SSFP normal values are shown.

CMR analysis methods {#Sec35}
--------------------

Measures of LVMT vary by the plane of acquisition (short axis versus long axis) \[[@CR29]\]. Measurements obtained on long axis images at the basal and mid-cavity level have been shown to be significantly greater compared to measurements on corresponding short axis images, whereas measurements obtained at the apical level of long axis images are significantly lower compared to short axis images. In recent publications, papillary muscles and trabeculations were excluded from measurements of left ventricular myocardial thickness \[[@CR29],[@CR30]\].

Demographic parameters {#Sec36}
----------------------

LVMT is greater in men than women \[[@CR29],[@CR30]\]. There are also small differences in LVMT in relationship to ethnicity and body size, but these variations are not likely to have clinical significance \[[@CR29]\]. Regarding age, one study of 120 healthy volunteers age 20--80 years reported an increase in myocardial thickness with age---starting after the fourth decade \[[@CR30]\]. In the study by Kawel el al. of 300 normal individuals without hypertension, smoking history or diabetes, there was no statistically significant difference in LVMT with age \[[@CR29]\].

Studies included in this review {#Sec37}
-------------------------------

There are two publications of a systematic analysis of left ventricular myocardial thickness based on SSFP imaging at 1.5T \[[@CR29],[@CR30]\]. In the study by Dawson et al., measurements were obtained on short axis images only. Kawel et al. published normal values of LVMT for long and short axis imaging (Tables [26](#Tab26){ref-type="table"}, [27](#Tab27){ref-type="table"} and [28](#Tab28){ref-type="table"}).Table 26**References, normal left ventricular myocardial thickness in adultsFirst author, yearCMR techniqueN, male: femaleAge range (yrs)**Dawson, 2011 \[[@CR30]\]Short axis SSFP, papillary muscle/ trabeculation excluded from LVMT60:6020-80Kawel, 2012 \[[@CR29]\]Short and long axis SSFP, papillary muscle/ trabeculation excluded from LVMT131:16954-91SSFP = steady-state free precession; yrs = years; LVMT = left ventricular myocardial thickness.Table 27**Normal left ventricular myocardial thickness in mm measured on long axis images for men and women according to** \[[@CR29]\]**MenWomenLevelRegionmeanSDLower/upper limits\*meanSDLower/upper limits\***basalanterior8.21.35.6-10.87.01.14.8-9.2inferior8.21.35.6-10.86.71.14.5-8.9septal9.11.36.5-11.77.31.15.1-9.5lateral7.61.35.0-10.26.01.13.8-8.2**mean**8.31.06.3-10.36.80.95.0-8.6mid-cavityanterior6.01.33.4-8.64.91.12.7-7.1inferior7.71.35.1-10.36.51.14.3-8.7septal8.31.35.7-10.96.81.14.6-9.0lateral6.61.34.0-9.25.31.13.1-7.5**mean**7.21.05.2-9.25.90.94.1-7.7apicalanterior5.11.32.5-7.74.21.12.0-6.4inferior5.81.33.2-8.45.01.12.8-7.2septal5.81.33.2-8.45.01.12.8-7.2lateral5.51.32.9-8.14.61.12.4-6.8**mean**5.61.03.6-7.64.70.92.9-6.5\* = calculated as mean ± (2\*SD).Table 28**Normal left ventricular myocardial thickness in mm measured on short axis images for men and womenMenWomenLevelSegmentmean** ~**p**~**SD** ~**p**~**Lower/upper limits\*mean** ~**p**~**SD** ~**p**~**Lower/upper limits\***basal18.21.16.0-10.46.71.04.7-8.729.61.17.4-11.87.91.05.9-9.939.21.17.0-11.47.51.05.5-9.548.11.15.9-10.36.61.04.6-8.657.31.15.1-9.56.01.04.0-8.067.41.15.2-9.66.10.94.3-7.9mid-cavity76.71.14.5-8.95.71.03.7-7.787.71.15.5-9.96.41.04.4-8.498.21.16.0-10.46.91.04.9-8.9107.01.14.8-9.25.91.03.9-7.9116.21.14.0-8.45.20.93.4-7.0126.41.14.2-8.65.41.03.4-7.4apical136.71.14.5-8.96.41.04.4-8.4147.31.15.1-9.56.31.04.3-8.3156.21.14.0-8.45.41.03.4-7.4166.31.14.1-8.55.91.03.9-7.9Pooled weighted mean values from references \[[@CR29],[@CR30]\].mean~p~ = pooled weighted mean; SD~p~ = pooled standard deviation; \* = calculated as mean~p~ ± 2\*SD~p~; Segments: 1 = basal anterior, 2 = basal anteroseptal, 3 = basal inferoseptal, 4 = basal inferior, 5 = basal inferolateral, 6 = basal anterolateral, 7 = mid anterior, 8 = mid anteroseptal, 9 = mid inferoseptal, 10 = mid inferior, 11 = mid inferolateral, 12 = mid anterolateral, 13 = apical anterior, 14 = apical septal, 15 = apical inferior, 16 = apical lateral.

Cardiac valves and quantification of flow {#Sec38}
=========================================

CMR acquisition parameters {#Sec39}
--------------------------

Prospectively and retrospectively ECG- gated phase contrast (PC) CMR sequences are available on most CMR machines. Prospectively-gated sequences use arrhythmia rejection and may be performed in a breath hold. Retrospectively gated techniques are mainly performed during free-breathing, often with higher spatial and temporal resolution compared to the breath hold techniques \[[@CR31]\]. 4D PC flow quantification techniques show initial promising results, but 2D PC flow techniques are currently used in the daily clinical routine \[[@CR32]\]. Apart from PC-CMR, valve planimetry---using ECG-gated SSFP CMR--- can also be used to estimate stenosis or insufficiencies with good correlation to echocardiographic measurements \[[@CR33]\].

Measurements of flow are most precise when a) the imaging plane is positioned perpendicular to the vessel of interest and b) the velocity encoded gradient echo (V~enc~) is encoded in a through plane direction \[[@CR34]\]. The slice thickness should be \<7 mm to minimize partial volume effects. Compared to aortic or pulmonary flow evaluation, quantification of mitral or tricuspid valves is more challenging using PC-CMR due to substantial through plane motion during the cardiac cycle \[[@CR35]\].

### Flow encoding velocity (V~enc~) {#Sec40}

The V~enc~ should be chosen close to the maximum expected flow velocity of the examined vessel for precise measurements. Setting the V~enc~ below the peak velocity results in aliasing. For the normal aorta and main pulmonary artery, maximum velocities do not exceed 150 and 90 cm/sec, respectively.

Adequate temporal resolution is necessary to avoid temporal flow averaging, especially for the evaluation of short, fast, and turbulent jets within a vessel (e.g. aortic stenosis). For the clinical routine, 25--30 msec temporal resolution is usually sufficient. The minimum required spatial resolution should be less than one third of the vessel diameter to avoid partial volume effects with the adjacent vessel wall and surrounding stationary tissues for small arteries \[[@CR34]\].

CMR analysis methods {#Sec41}
--------------------

For data analysis, dedicated flow software should be used. Most of the currently available flow software tools offer semi-automatic vessel contouring, which needs to be carefully checked by the examiner.

The modified Bernoulli equation (∆P = 4 × V~max~^2^) is commonly used for calculation of pressure gradients using PC-CMR across the pulmonary or aortic valve \[[@CR36],[@CR37]\].

It has to be considered that velocity measurements of a stenotic lesion with high jet velocities might be inaccurate due to partial volume effects in case of a small jet width and also the limited temporal resolution compared to the high velocity of the jet. Measurements are further affected by signal loss due to the high velocity that may lead to phase shift errors and dephasing. Misalignement of the slice relative to the direction of the jet may lead to an underestimation of the peak velocity \[[@CR38]\].

Demographic parameters {#Sec42}
----------------------

To our knowledge, data of the association between normal values of flow and valve planimetry with demographic parameters has not been previously published.

Studies included in this review {#Sec43}
-------------------------------

There is good agreement between PC-CMR, SSFP CMR planimetry, and echocardiography measurements, American Heart Association (AHA) criteria for grading valve stenosis or insufficiency is suggested \[[@CR33],[@CR39],[@CR40]\] (Table [29](#Tab29){ref-type="table"}). To date, there is no publication of normal reference values of flow and valve planimetry based on CMR measurements.Table 29**Grading valve disease adapted from echocardiography** \[[@CR39],[@CR41]\]**Valve diseaseIndicatorMildModerateSevere**Aortic stenosisPeak velocity \[m/s\]\<33-4\>4Orifice area \[cm^2^\]\>1.51.0-1.5\<1.0Orifice area /BSA \[cm^2^/m^2^\]\<0.6Aortic regurgitationRegurgitant volume \[ml/beat\]\<3030-59≥60Regurgitant fraction \[%\]\<3030-49≥50Regurgitant orifice area \[cm^2^\]\<0.100.10-0.29≥0.30Mitral stenosisPeak velocity \[m/s\]\<1.21.2-2.2\>2.2Orifice area \[cm^2^\]\>1.51.0-1.5\<1.0Mitral regurgitationRegurgitant volume \[ml/beat\]\<3030-59≥60Regurgitant fraction \[%\]\<3030-49≥50Regurgitant orifice area \[cm^2^\]\<0.200.20-0.39≥0.40Pulmonary stenosisPeak velocity \[m/s\]\<33-4\>4Orifice area \[cm^2^\]\<1Pulmonary regurgitationRegurgitant volume \[ml/beat\]\<3030-40\>40Regurgitant fraction \[%\]\<2520-35\>35Tricuspid stenosisOrifice area \[cm^2^\]\<1.0

Mitral valve flow velocities and deceleration time as for determination of diastolic left ventricular function measured by CMR showed a good correlation with measurements derived by transthoracic echocardiography but with a systematic underestimation \[[@CR42]\] (Table [30](#Tab30){ref-type="table"}).Table 30**Mitral valve flow for determination of diastolic left ventricular function according to reference** \[[@CR43]\]**ParameterNormalType 1 (Impaired relaxation)Type 2 (Pseudonormal)Type 3 (Restrictive, partially reversible)Type 3 (Restrictive, fixed)**MDT (ms)150-220IncreasedNormalDecreasedDecreasedE/A ratio1-2\<11-2\>2\>2MDT = mitral deceleration time; E/A ratio = ratio of the mitral early (E) and atrial (A) components of the mitral inflow velocity profile.

Normal aortic dimensions in the adult {#Sec44}
=====================================

CMR acquisition parameters {#Sec45}
--------------------------

Three- dimensional contrast enhanced MR Angiography (MRA) has gained broad acceptance and is widely used for assessment and follow-up of thoracic aortic diameter in clinical setting. The multi-planar reformation of MRA images leads to an accurate measurement perpendicular to the lumen of the vessel. However, the need of a contrast injection is a limitation for the use of this technique in patients who need multiple follow up examinations and in population based study settings \[[@CR44]\]. Alternatively non-contrast techniques such as ECG gated non contrast 3D (2D) balanced steady state free precession (SSFP) CMR can be applied. The modulus image of phase contrast CMR has also been used to measure diameters of the aorta \[[@CR45]\]. 2D Black blood CMR is used for a more detailed aortic wall assessment. In 2D acquisitions, the imaging plane needs to be acquired correctly at the time of the scan; thus any alterations in the imaging plane will result in a higher variability and lower accuracy of measurements. Another limitation for ascending thoracic aorta diameter measurement is the through plane motion during the cardiac cycle which can be minimized with ECG gating \[[@CR44]\]. Potthast and colleagues compared the diameter of the ascending aorta obtained by different CMR sequences to ECG-triggered CT angiography as the gold standard and reported that ECG gated navigator triggered 3D SSFP sequence showed the best agreement with CT \[[@CR44]\].

CMR analysis methods {#Sec46}
--------------------

It is important to indentify the anatomic locations of diameter measurements of the thoracic aorta. In the studies cited here, measurements were obtained at the following anatomic locations: 1. aortic root cusp-commissure and cusp-cusp measurements; 2. aortic valve annulus; 3. aortic sinus; 4. sinotubular junction; 5. ascending aorta and proximal descending aorta: measurements at the level of the right pulmonary artery; 6. abdominal aorta: 12 cm distal to the pulmonary artery (Figure [13](#Fig13){ref-type="fig"}).Figure 13**The anatomic locations of aorta measurements: A. aortic valve annulus; B. aortic sinus; C. sinotubular junction; D. ascending aorta and proximal descending aorta; E. abdominal aorta.**

The sagittal oblique view of the left ventricular outflow tract was used for measuring diameter at the level of the aortic annulus, the aortic sinus, and the sinotubular junction. Axial cross sectional images at predefined anatomic levels were used for measuring the ascending and descending aorta \[[@CR46]\] as well as cusp-commissure and cusp-cusp diameters at the level of the aortic sinus \[[@CR47]\] (Figures [13](#Fig13){ref-type="fig"} and [14](#Fig14){ref-type="fig"}). There is no definite convention about measuring the luminal or outer to outer diameter of the aorta. Usually, measurement technique depends on the resolution and characteristics of the available MRI sequence. In the tables below, the method is specified.Figure 14**Cusp-commissure (continuous lines) and cusp-cusp (dashed-lines) measurements at the level of the aortic sinus.**

Demographic parameters {#Sec47}
----------------------

Age, gender and body size are major determinants of physiologic variation in aortic size. In the Multi-Ethnic Study of Atherosclerosis, which included participants from four different ethnicities, the race/ethnicity were not clinically significant determinants of ascending aorta diameter \[[@CR45]\].

Aortic diameter and ascending aorta length increase with age, leading to decreased curvature of the aortic arch \[[@CR48],[@CR49]\]. The association of age with aortic diameter was more marked in the ascending aorta compared to the descending thoracic and abdominal aorta, respectively \[[@CR50],[@CR51]\]. Additionally, the descending aorta did not demonstrate age associated lengthening \[[@CR49]\].

Studies included in this review {#Sec48}
-------------------------------

Studies with normal values of aortic diameters including 50 or more subjects for both men and women and a range of ages (due to the age dependence of aortic diameters) have been included in this review (Tables [31](#Tab31){ref-type="table"}, [32](#Tab32){ref-type="table"}, [33](#Tab33){ref-type="table"}, [34](#Tab34){ref-type="table"} and [35](#Tab35){ref-type="table"}). There are three major publications regarding MR-based measurements of the thoracic aorta in adults: Davis et al. determined aortic diameter at three levels (ascending aorta, proximal descending aorta and abdominal aorta) by calculating the luminal diameter based on measurements of the cross sectional area obtained on cine SSFP images \[[@CR46]\]. In the original publication normal age and gender specific absolute and indexed (for BSA) values are presented in a graph and absolute numbers are presented for different weight categories (Table [32](#Tab32){ref-type="table"}).Table 31**References, normal aortic dimensions in adultsFirst author, yearCMR techniqueN, male: femaleAge range (yrs)**Davis, 2014 \[[@CR46]\]SSFP; luminal diameter of thoracic and abdominal aorta208: 23919-70Turkbey, 2013 \[[@CR45]\]Phase contrast (magnitude image); luminal diameter of ascending thoracic aorta770:84245-84Burman, 2008 \[[@CR47]\]SSFP; luminal diameter of aortic root60:6020-80SSFP = steady-state free precession; yrs = years.Table 32**Normal values (in mm) of the thoracic and abdominal aortic luminal diameters for men and women of different BMI categories measured at diastole (mean\[±2SD\]) according to** \[[@CR46]\]**MenWomenLevelNormal weightOverweightObeseNormal weightOverweightObeseAortic annulus**23.9 (18.6-29.2)24.3 (18.9-29.7)25.6 (20.4-30.8)20.6 (17.4-23.8)21.7 (18.4-25.0)21.5 (17.2-25.8)**Aortic sinus**31.9 (24.3-39.5)32.8 (25.2-40.4)33.3 (24.3-42.3)27.5 (21.9-33.1)28.0 (21.8-34.2)27.5 (21.3-33.7)**Sinotubular junction**24.4 (18.2- 30.6)25.7 (16.7- 34.7)26.2 (18.9- 33.5)21.6 (16.6- 26.6)22.3 (17.0- 27.6)22.1 (15.9- 28.3)**Ascending aorta**26.0 (18.7-33.3)27.4 (18.9-35.9)28.5 (23.1-33.9)24.7 (17.8-31.6)26.5 (19.3-33.7)26.6 (18.8-34.4)**Prox. desc. aorta**20.1 (14.7-25.5)20.9 (15.6-26.2)22.2 (16.3-28.1)18.5 (14.6-22.4)19.2 (14.8-23.6)19.6 (16.5-23.2)**Abdominal aorta \***17.1 (12.0-22.2)17.9 (12.8-23.0)18.8 (14.4-23.2)16.0 (12.1-19.9)16.3 (12.3-20.3)17.4 (13.9-20.9)normal weight = BMI \<25 kg/m^2^; overweight = BMI 25--29.9 kg/m^2^; obese = BMI \>30 kg/m^2^; prox. desc. aorta = proximal descending aorta; \* = abdominal aorta measured 12 cm distal to the pulmonary artery.Table 33**Absolute and BSA indexed normal values of ascending aortic luminal diameter for men and women of different age categories (median \[5th-95th percentile\]) measured on phase contrast images according to** \[[@CR45]\]**Age (years)MenWomenAbsolute values (mm)45-54**31.6 (27.2-37.3)28.8 (24.6-34.4)**55-64**32.8 (28.1-40.7)30.1 (25.7-36.4)**65-74**34.2 (28.7-41.0)30.6 (26.1-36.3)**75-84**34.7 (28.6-40.8)31.1 (26.8-37.1)**Values indexed to BSA (mm/m** ^**2**^ **)45-54**15.9 (13.3-19.5)16.7 (13.5-20.7)**55-64**16.8 (13.6-21.1)17.6 (14.8-22.1)**65-74**17.8 (14.2-21.8)18.1 (14.5-22.1)**75-84**18.6 (15.2-22.6)19.7 (15.3-28.2)BSA = body surface area.Table 34**Absolute and indexed (to BSA) normal values of aortic root cusp-commissure measurements for men and women of different age categories measured at systole and diastole (mean ± SD \[lower/upper limits calculated as mean ± 2SD\]) according to** \[[@CR47]\]**MenWomenAge (years)systolicdiastolicsystolicdiastolicAbsolute values (mm)20-29**32.6 ± 3.5 (26--40)30.4 ± 3.3 (24--37)28.6 ± 3.9 (21--36)26.3 ± 3.9 (19--34)**30-39**32.0 ± 3.3 (25--39)29.7 ± 3.5 (23--37)28.5 ± 2.8 (23--34)26.8 ± 2.8 (21--32)**40-49**33.3 ± 2.1 (29--38)31.6 ± 1.6 (28--35)31.7 ± 2.8 (26--37)30.0 ± 2.1 (26--34)**50-59**33.9 ± 5.1 (24--44)32.7 ± 4.8 (23--42)29.5 ± 2.0 (26--34)28.4 ± 1.8 (25--32)**60-69**34.6 ± 2.5 (30--40)33.5 ± 2.3 (29--38)30.5 ± 1.9 (27--34)29.5 ± 2.0 (26--34)**70-79**35.1 ± 3.1 (29--41)33.9 ± 3.0 (28--40)30.7 ± 1.3 (28--33)29.6 ± 1.4 (27--32)**all**33.6 ± 3.4 (27--40)32.0 ± 3.5 (25--39)29.9 ± 2.7 (25--35)28.4 ± 2.8 (23--34)**Values indexed to BSA (mm/m** ^**2**^ **)20-29**16.8 ± 1.6 (14--20)15.6 ± 1.7 (12--19)16.7 ± 1.9 (13--21)15.3 ± 2.0 (11--19)**30-39**16.3 ± 1.6 (13--20)15.1 ± 1.6 (12--18)17.5 ± 1.3 (15--20)16.4 ± 1.3 (14--19)**40-49**16.1 ± 1.1 (14--18)15.3 ± 1.0 (13--17)17.8 ± 2.6 (13--23)16.8 ± 2.3 (12--21)**50-59**17.2 ± 2.1 (13--21)16.6 ± 1.9 (13--20)17.8 ± 1.4 (15--21)17.2 ± 1.4 (14--20)**60-69**17.7 ± 1.8 (14--21)17.2 ± 1.7 (14--21)17.7 ± 1.5 (15--21)17.1 ± 1.4 (14--20)**70-79**18.0 ± 1.2 (16--20)17.4 ± 1.2 (15--20)18.5 ± 0.9 (17--20)17.8 ± 0.9 (16--20)**all**17.0 ± 1.7 (14--20)16.2 ± 1.8 (13--20)17.7 ± 1.7 (14--21)16.8 ± 1.7 (13--20)BSA = body surface area.Table 35**Absolute and indexed (to BSA) normal values of aortic root cusp-cusp measurements for men and women of different age categories measured at systole and diastole (mean ± SD \[lower-upper limits calculated as mean ± 2\*SD\]) according to** \[[@CR47]\]**MenWomenAge (years)systolicdiastolicsystolicdiastolicAbsolute values (mm)20-29**34.4 ± 4.2 (26--43)32.8 ± 3.8 (25--40)30.2 ± 4.7 (21--40)28.4 ± 4.7 (19--38)**30-39**33.8 ± 3.8 (26--41)32.0 ± 3.9 (24--40)30.0 ± 3.1 (24--36)28.7 ± 3.0 (23--35)**40-49**36.0 ± 2.7 (31--41)34.1 ± 2.3 (30--39)33.9 ± 2.5 (29--39)32.8 ± 2.5 (28--38)**50-59**36.3 ± 5.9 (25--48)35.2 ± 5.7 (24--47)31.4 ± 2.5 (26--36)30.6 ± 2.6 (25--36)**60-69**37.4 ± 2.9 (32--43)36.2 ± 2.5 (31--41)32.8 ± 2.3 (28--37)32.0 ± 2.2 (28--36)**70-79**37.8 ± 3.9 (30--46)37.0 ± 3.5 (30--44)32.9 ± 1.7 (30--36)32.0 ± 1.6 (29--35)**all**36.0 ± 4.1 (28--44)34.6 ± 4.0 (27--43)31.9 ± 3.2 (26--38)30.7 ± 3.3 (24--37)**Values indexed to BSA (mm/m** ^**2**^ **)20-29**17.7 ± 1.9 (14--22)16.9 ± 1.9 (13--21)17.6 ± 2.3 (13--22)16.6 ± 2.3 (12--21)**30-39**17.2 ± 2.0 (13--21)16.2 ± 1.9 (12--20)18.4 ± 1.4 (16--21)17.6 ± 1.3 (15--20)**40-49**17.4 ± 1.4 (15--20)16.5 ± 1.3 (14--19)19.0 ± 2.7 (14--24)18.4 ± 2.5 (13--23)**50-59**18.5 ± 2.4 (14--23)17.9 ± 2.3 (13--23)18.9 ± 1.7 (16--22)18.5 ± 1.8 (15--22)**60-69**19.2 ± 2.2 (15--24)18.6 ± 2.0 (15--23)19.0 ± 1.8 (15--23)18.6 ± 1.6 (15--22)**70-79**19.4 ± 1.4 (17--22)19.0 ± 1.3 (16--22)19.8 ± 1.0 (18--22)19.3 ± 1.0 (17--21)**all**17.6 ± 2.0 (14--22)17.5 ± 2.0 (14--22)18.8 ± 1.9 (15--23)18.1 ± 2.0 (14--22)BSA = body surface area.

Turkbey et al. measured the luminal diameter of the ascending aorta on magnitude images of a phase contrast sequence in a large number of healthy subjects \[[@CR45]\] (Table [33](#Tab33){ref-type="table"}).

Burmann et al. performed detailed measurements of the aortic root including cusp-commissure and cusp-cusp measurements at diastole and systole on cine SSFP images \[[@CR47]\] (Tables [34](#Tab34){ref-type="table"} and [35](#Tab35){ref-type="table"}).

Normal aortic dimensions in children {#Sec49}
====================================

CMR acquisition parameters {#Sec50}
--------------------------

There is no consensus regarding the sequence type used to measure aortic diameters and areas. In the three major publications (Table [36](#Tab36){ref-type="table"}) measurements were obtained on 3 dimensional contrast enhanced MR angiography \[[@CR52]\], gradient echo images \[[@CR53]\] and phase contrast cine images \[[@CR54]\].Table 36**References, normal aortic dimensions in childrenFirst author, yearCMR techniqueN, male: femaleAge range (yrs)**Kaiser, 2008 \[[@CR52]\]Contrast enhanced 3D MR angiography; shortest diameter30:232-20Voges, 2012 \[[@CR53]\]Cine GRE; measurements obtained at maximal distension of the aorta30:412.3-28.3Kutty, 2012 \[[@CR54]\]Cine phase contrast CMR; measurements obtained at systole55:504.4-20.4GRE = gradient echo; 3D = 3-dimensional; yrs = years.

CMR analysis methods {#Sec51}
--------------------

In order to reduce error in measurement, care has to be taken to obtain or reconstruct cross sectional images that are true perpendicular instead of oblique to the course of the vessel. Kaiser et al. demonstrated that aortic diameter measurements show a slight variation with measurement plane with a mean difference between measurements on cross-sectional and longitudinal images of 0.16 mm and a coefficient of variability of 2.1% \[[@CR52]\].

Kutty et al. indicate that in their study the outer diameter of the vessel was measured \[[@CR54]\] while Kaiser et al. and Voges et al. do not mention details in this respect \[[@CR52],[@CR53]\].

Demographic parameters {#Sec52}
----------------------

Aortic diameters vary by BSA \[[@CR52],[@CR54]\] but do not show gender differences \[[@CR53],[@CR54]\]. Aortic area did also not show any gender differences \[[@CR53]\].

Studies included in this review {#Sec53}
-------------------------------

There are three publications of a systematic evaluation of aortic dimensions (diameter and/or area) in children that vary by CMR-technique, measurement technique and data presentation (Table [36](#Tab36){ref-type="table"}): In the study by Kaiser et al. aortic diameter was measured as the shortest diameter passing the center of the vessel at 9 levels of the thoracic aorta on reconstructed cross-sectional images of a contrast enhanced 3 dimensional MR angiography \[[@CR52]\]. In the original publication data is presented as median and range as well as percentiles, z-scores and regression models incorporating BSA. Voges et al. present measurements obtained at four levels of the thoracic aorta obtained on cine GRE images at maximal aortic distension as mean ± standard deviation and as percentiles \[[@CR53]\]. In the study by Kutty et al. aortic diameter and area was measured 1-2 cm distal to the sinotubular junction at systole on phase contrast cine images \[[@CR54]\]. Data is presented as mean ± standard deviation, regression equation and z-scores.

In this review we present regression equations of normal aortic diameters measured at 9 different sites according to \[[@CR52]\] (Table [37](#Tab37){ref-type="table"}, Figure [15](#Fig15){ref-type="fig"}) and of normal area of the ascending aorta according to \[[@CR54]\] (Table [38](#Tab38){ref-type="table"}). Further reference percentiles of aortic area measured at 4 different locations obtained on cine GRE images are presented in Figure [16](#Fig16){ref-type="fig"} according to \[[@CR53]\]. The z-scores for each aortic diameter (D) can be calculated with the following equation:Table 37**Normal aortic diameters (in mm) measured on reconstructed cross-sectional images of a contrast enhanced 3D-MR angiography according to reference** \[[@CR52]\]**SitePredicted diameterSD of residuals**Aortic sinus0.57 + 19.37\*BSA^0.5^2.38Sinotubular junction−0.03 + 16.91\*BSA^0.5^1.92Ascending aorta−1.33 + 18.6\*BSA^0.5^1.99Proximal to the origin of the brachiocephalic artery−3.38 + 20.07\*BSA^0.5^1.69First transverse segment−3.52 + 18.66\*BSA^0.5^1.63Second transverse segment−2.63 + 16.5\*BSA^0.5^1.31Isthmic region−3.37 + 16.52\*BSA^0.5^1.46Descending aorta−1.12 + 14.42\*BSA^0.5^1.64Thoracoabdominal aorta at the level of the diaphragm1.27 + 9.89\*BSA^0.5^1.34BSA = body surface area; SD = standard deviation.Figure 15**Sites of measurement.** AS = aortic sinus; STJ = sinotubular junction; AA = ascending aorta; BCA = proximal to the origin of the brachiocephalic artery; T1 = first transverse segment; T2 = second transverse segment; IR = isthmic region; DA = descending aorta; D = thoracoabdominal aorta at the level of the diaphragm.Table 38**Normal aortic area (in cm** ^**2**^ **) measured 1-2 cm distal to the sinotubular junction at systole on phase contrast cine images according to reference** \[[@CR54]\]**SitePredicted diameter**Ascending aorta−0.0386 + 2.913\*BSABSA = body surface area.Figure 16**Reference percentiles for aortic areas measured at four different sites (ascending aorta \[a\], aortic arch \[b\], aortic isthmus \[c\] and descending aorta above the diaphragm \[d\]) on cine GRE images at maximal aortic distension according to reference \[** [@CR53] **\].**$$\documentclass[12pt]{minimal}
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on the base of the data provided in Table [37](#Tab37){ref-type="table"}.

Due to the differences in acquisition and measurement technique as well as presentation of results, weighted mean values were not calculated.

Normal aortic distensibility/ pulse wave velocity in adults {#Sec54}
===========================================================

CMR acquisition parameters {#Sec55}
--------------------------

Pulse wave velocity (PWV) calculations using a velocity-encoded CMR with phase contrast sequences allow accurate assessment of aortic systolic flow wave and the blood flow velocity. The sequence should be acquired at the level of the bifurcation of the pulmonary trunk, perpendicular to both, the ascending and descending aorta. The distance between two aortic locations (aortic length) can be estimated from axial and coronal cine breath hold SSFP sequences covering the whole aortic arch \[[@CR55]\]. Alternatively, sagittal oblique views of the aortic arch can be acquired using a black blood spin echo sequence \[[@CR51]\].

Another measurement method of aortic stiffness is aortic distensibility. The cross sectional aortic area at different phases of the cardiac cycle is measured using ECG-gated SSFP cine imaging to assess aortic distensibility by CMR. Modulus images of cine phase contrast CMR can be used as well \[[@CR56]\].

CMR analysis methods {#Sec56}
--------------------

PWV is the most validated method to quantify arterial stiffness using CMR. PWV is calculated by measuring the pulse transit time of the flow curves (Δt) and the distance (D) between the ascending and descending aortic locations of the phase contrast acquisition \[[@CR51]\]: Aortic PWV = D/ Δt (Figure [17](#Fig17){ref-type="fig"}).Figure 17**Measurement of pulse wave velocity according to reference** **\[** [@CR53] **\]** **.** Δx = length of the centerline between the sites of flow measurement in the ascending and descending aorta **(A)**; Δt = time delay between the flow curves obtained in the descending aorta relative to the flow curve obtained in the ascending aorta calculated between the midpoint of the systolic up slope tails on the flow versus time curves of the ascending aorta (ta1) and the descending aorta (ta2) **(B)**.

PWV increases with stiffening of arteries since the stiffened artery conducts the pulse wave faster compared to more distensible arteries.

Aortic distensibility is calculated with the fallowing formula after measuring the minimum and maximum aortic cross sectional area \[[@CR57]\]:

Aortic Distensibility = (minimum area- maximum area)/ (minimum area x ΔP x 1000) where ΔP is the pulse pressure in mmHg.

Demographic parameters {#Sec57}
----------------------

Greater ascending aorta diameter and changes in aortic arch geometry by aging was significantly associated with increased regional stiffness of the aorta, especially the ascending portion. The relationship of age with measures of aortic stiffness is non --linear and the decrease of aortic distensibility is steeper before the fifth decade of life \[[@CR51]\]. Males have stiffer aortas compared to females \[[@CR58]\].

Studies included in this review {#Sec58}
-------------------------------

Two publications reported normal values of pulse wave velocity and aortic distensibility (Tables [39](#Tab39){ref-type="table"}, [40](#Tab40){ref-type="table"} and [41](#Tab41){ref-type="table"}).Table 39**References, ascending and descending thoracic aorta distensibility, aortic arch pulse wave velocityFirst author, yearCMR techniqueN, male: femaleAge range (yrs)**Redheuil, 2010 \[[@CR51]\]Phase contrast CMR and gradient echo cine54:5720-84Rose, 2010 \[[@CR58]\]SSFP13:1323-61yrs = years; SSFP = steady-state free precession.Table 40**Normal values of ascending and descending thoracic aorta distensibility and aortic arch pulse wave velocity by age categories (mean ± SD) according to** \[[@CR51]\]**Age categories (years)20-2930-3940-4950-5960-69≥70Ascending aortic distensibility (kPa** ^**−1**^ **. 10** ^**−3**^ **)**74 ± 2361 ± 2331 ± 1818 ± 712 ± 710 ± 6**Descending aortic distensibility (kPa** ^**−1**^ **. 10** ^**−3**^ **)**72 ± 1870 ± 2438 ± 1729 ± 1318 ± 817 ± 6**Aortic arch PWV (m/s)**3.5 ± 0.53.9 ± 1.15.6 ± 1.47.2 ± 2.39.7 ± 2.911.1 ± 4.6PWV = Pulse wave velocity.Table 41**Normal values of ascending and descending thoracic aorta distensibility (in 10** ^**−3**^  **mmHg** ^**−1**^ **) by gender (mean ± SD) according to** \[[@CR58]\]**MenWomenAscending Aorta**6.1 ± 2.58.6 ± 2.7**Descending Aorta**5.1 ± 2.47.2 ± 1.6

Normal aortic distensibility/ pulse wave velocity in children {#Sec59}
=============================================================

CMR acquisition parameters {#Sec60}
--------------------------

In the only publication of aortic distensibility and pulse wave velocity in children, distensibility was measured on gradient echo cine CMR images and pulse wave velocity was measured on phase-contrast cine CMR \[[@CR53]\].

CMR analysis methods {#Sec61}
--------------------

Distensibility was calculated as (A~max~ -- A~min~)/A~min~ x (P~max~ -- P~min~), where A~max~ and A~min~ represent the maximal and minimal cross-sectional areal of the aorta, and P~max~ and P~min~ represent the systolic and diastolic blood pressure measured with a sphygmomanometer cuff around the right arm.

Pulse wave velocity was calculated as Δx/Δt, where Δx is defined as the length of the centerline between the sites of flow measurement in the ascending and descending aorta and Δt represents the time delay between the flow curve obtained in the descending aorta relative to the flow curve obtained in the ascending aorta (Figure [17](#Fig17){ref-type="fig"}).

Demographic parameters {#Sec62}
----------------------

Aortic distensibility and pulse wave velocity did not vary by gender. Aortic distensibility decreases with age and correlates with height, body weight and BSA \[[@CR53]\].

Studies included in this review {#Sec63}
-------------------------------

There is a single publication only of a systematic evaluation of normal aortic distensibility and pulse wave velocity in children (Table [42](#Tab42){ref-type="table"}). Reference percentiles by age according to reference \[[@CR53]\] are presented in Figures [18](#Fig18){ref-type="fig"} and [19](#Fig19){ref-type="fig"}.Table 42**References, normal aortic distensibility and pulse wave velocity in childrenFirst author, yearCMR techniqueN, male: femaleAge range (yrs)**Voges, 2012 \[[@CR53]\]Cine GRE; phase-contrast cine CMR30:412.3-28.3GRE = gradient echo; yrs = years.Figure 18**Reference percentiles for aortic distensibility measured at four different sites (ascending aorta \[a\], aortic arch \[b\], aortic isthmus \[c\] and descending aorta above the diaphragm \[d\]) on cine GRE images at maximal aortic distension according to reference \[** [@CR53] **\].**Figure 19**Reference percentiles for aortic pulse wave velocity according to reference \[** [@CR53] **\].**

Normal values of myocardial T1 relaxation time and the extracellular volume (ECV) {#Sec64}
=================================================================================

CMR acquisition parameters {#Sec65}
--------------------------

Most of the published myocardial T1 values have been acquired using a Modified Look-Locker Inversion Recovery (MOLLI) \[[@CR59]\] or shortened-MOLLI (ShMOLLI) \[[@CR60]\] method, combined with a balanced SSFP read out \[[@CR59]\]. The MOLLI method acquires data over 17 heartbeats with a 3(3bt)3(3bt)5 sampling pattern, while ShMOLLI has been described with a 9 heart beat breath-hold and a 5(1bt)1(1bt)1 sampling pattern, although variations of these acquisition schemes have been proposed \[[@CR60]\]. An alternative sampling method is saturation recovery single-shot acquisition (SASHA) in which a first single-shot bSSFP image is acquired without magnetization preparation followed by nine images prepared with variable saturation recovery times \[[@CR61]\]. All methods usually acquire images at end diastole to limit cardiac motion artifacts \[[@CR59]\] but acquisition of T1 maps at systole has been shown to be feasible \[[@CR62]\]. Post contrast T1 values have been performed following a bolus or primed infusion (Equilibrium-EQCMR) with good agreement of ECV values up to 40% \[[@CR63]\].

### Factors affecting T1 and ECV {#Sec66}

Field strength has a significant effect on T1 values; with 3T scans producing 28% higher native T1 and 14% higher post contrast T1 values when compared with 1.5T \[[@CR62]\]. Post contrast T1 is also affected by the dose and relaxivity of the contrast agent used, contrast clearance, and the time between injection and measurement \[[@CR62],[@CR64],[@CR65]\]. There is also greater heterogeneity for a T1 native normal range at 3 Tesla \[[@CR62],[@CR66],[@CR67]\]. Further, it has been shown that T1 varies by cardiac phase (diastole versus systole) and region of measurement (septal versus non-septal) \[[@CR62]\]. ECV values are relatively unaffected by field strength (3T versus 1.5T). Both native T1 and ECV values have been shown to be less reliable in the infero-lateral wall \[[@CR62],[@CR68]\].

Flip-angle and pre-pulse can also affect normal values, with the adiabatic pre-pulse increasing native T1 values by approximately 25 ms compared with non-adiabatic pre-pulses. FLASH mapping sequences produce significantly lower native T1 values than bSSFP methods \[[@CR69],[@CR70]\].

CMR analysis methods {#Sec67}
--------------------

T1 maps are based on pixel-wise quantification of longitudinal relaxation of the acquired images. Native T1 measures a composite signal from myocytes and interstitium and is expressed in ms \[[@CR71]\]. Measurements that correlate pre and post contrast T1 myocardial values and blood T1 have been proposed, such as the partition coefficient or the extracellular volume fraction (ECV), expressed as a percantage \[[@CR72]\].

Offline post-processing involves manually tracing endocardial and epicardial contours \[[@CR65],[@CR73]\] (Figure [20](#Fig20){ref-type="fig"}) or placing a region of interest within the septal myocardium using a prototype tool \[[@CR67]\]. Inclusion of blood pool or adjacent tissue should be carefully avoided. Motion correction is generally used to counter undesired breathing motion. However, motion correction can only correct for in-plane motion and not through-plane motion. All methods, therefore, are vulnerable to partial volume effects. Some investigators also corrected for this with smaller regions of interest and co-registration of images \[[@CR74]\].Figure 20**T1 maps pre- and post-contrast with left ventricular endocardial and epicardial contours.**

Demographic parameters {#Sec68}
----------------------

Increasing age has been shown to increase ECV in healthy volunteers in one publication \[[@CR68]\] and females less than 45 years have been shown to have a higher precontrast T1 \[[@CR74]\].

Studies included in this review {#Sec69}
-------------------------------

Several studies have shown a strong correlation between T1 values by CMR and diffuse myocardial fibrosis on myocardial biopsy \[[@CR71],[@CR75],[@CR76]\], but the rapid evolution of acquisition methods over the past years has led to inconsistent T1 values reported in the literature.

In order to reflect the current literature, the normal values presented here are classified by field strength and acquisition pulse sequence and list pre contrast, post contrast, and ECV values where available.

It should be noted that a universal normal range for T1 cannot be determined given the heterogeneity of acquisition pulse sequences used in the existing literature and because no true reference value for in vivo T1 exists. Table [43](#Tab43){ref-type="table"} is a summary of publications over the last years presenting normal values based on ≥ 20 healthy subjects as available in December 2013.Table 43**Normal native and post contrast T1 time and ECV (mean ± SD)AuthornAge (yrs)Male (%)SequenceGd type & dose (mmol/kg)Time p.c. (min)T1 native (ms)T1 p.c. (ms)ECVSlice(s), % thickness1.5 Tesla**Iles (2008) \[[@CR77]\]2038 ± 350GE, VAST 3--4 BH0.2 Magnevist15975 ± 62564 ± 23n/a3x SAX & 4Ch full thicknessUgander (2012) \[[@CR68]\]6049 ± 1752MOLLI0.15-0.2 Magnevist15-20Not reportedNot reported27 ± 31x SAX & 4Ch full thicknessKellman (2012) \[[@CR78]\]6244 ± 1748MOLLI0.15 Magnevist15-20965 ± 35Not reported25 ± 3\*\*1x SAX & 4Ch midwallFlett (2012) \[[@CR69]\]3064 ± 1367FLASH, multi-BH0.1 Dotarem45-80 EQCMR698 ± 86408 ± 33n/a2x SAX septumFontana (2012) \[[@CR76]\]5047 ± 753ShMOLLI\*0.1 Dotarem45-80 EQCMRNot reportedNot reported26 ± 32x SAX septumSado (2012) \[[@CR70]\]8144 ± 1752FLASH, multi-BH0.1 Dotarem45-80 EQCMRNot reportedNot reported25 ± 42x SAX septumKawel (2012) \[[@CR62]\]2328 ± 636MOLLI0.15 Magnevist121003 ± 46522 ± 3428 ± 31x SAX full thicknessPiechnik (2013) \[[@CR74]\]34238 ± 1549ShMOLLI\*No contrast givenn/a962 ± 25n/an/a3x SAX full thicknessBull (2013) \[[@CR75]\]3362 ± 764ShMOLLINo contrast givenn/a944 ± 16n/an/a1x SAX septal midwall**3 Tesla**Kawel (2012) \[[@CR65]\]2328 ± 631MOLLI0.15 Magnevist121286 ± 59538 ± 3428 ± 31x SAX full thicknessKawel (2012) \[[@CR65]\]2328 ± 633MOLLI0.1 Multihance12As above555 ± 3327 ± 31x SAX full thicknessPuntmann (2013) \[[@CR67]\]2138 ± 623MOLLI\*0.2 Gadobutrol151056 ± 27454 ± 5326 ± 51x SAX septal midwallPuntmann (2013) \[[@CR79]\]3043 ± 963MOLLI\*0.2 Gadobutrol101070 ± 55402 ± 5827 ± 51x SA septal midwallLiu (2012) \[[@CR80]\]2429 ± 633MOLLI0.15 Magnevist121159 ± 39Not reported27 ± 31x SAX full thicknessLiu (2012) \[[@CR80]\]2429 ± 633MOLLI0.1 Multihance121159 ± 39Not reported26 ± 31x SAX full thicknessAge: mean ± standard deviation; yrs = years; n = number of subjects; Gd = Gadolinium; p.c. = post contrast; ECV = extracellular volume fraction; MOLLI = modified look-locker inversion recovery; ShMOLLI = shortened MOLLI; GE = gradient echo; VAST = variable sampling of k-space; BH = breath hold; LL = Look-locker; FLASH = fast low angle single shot recovery; SAX = short axis; 4Ch = 4 chamber; Hb = heart beat; EQCMR = equilibrium contrast cardiovascular magnetic resonance; \* = adiabatic pre pulse; \*\* = automated motion correction and co-registration.

For SASHA, only limited normal values are available. T1 estimates based on SASHA are higher than with MOLLI methods. One study reported SASHA derived T1 values in 39 normal subjects of 1170 ± 9 ms at 1.5T \[[@CR61]\].

We conclude that at present, normal native T1 values are specific to pulse sequences and scanner manufacturer. For diagnostic purposes it is most important to use a method with a tight normal range, good reproducibility and sensitivity to disease.

Normal values of myocardial T2\* relaxation time {#Sec70}
================================================

CMR acquisition parameters {#Sec71}
--------------------------

Quantification of the T2\* relaxation time plays an important role for estimation of myocardial iron overload \[[@CR81]\]. For quantification of the myocardial T2\* time, the gradient-echo T2\* technique with multiple increasing TEs is preferred over the spin-echo T2 technique due to a greater sensitivity to iron deposition \[[@CR82]-[@CR84]\]. Usually a single-breath hold technique is used. Normal values and a grading system for myocardial iron overload are available for 1.5T \[[@CR84]\].

CMR analysis methods {#Sec72}
--------------------

Since the gradient-echo T2\* technique is vulnerable to distortions of the local magnetic field e.g. by air-tissue interfaces, measurements are obtained by placing a region of interest on the interventricular septum of a midventricular short axis slice, since the septum is surrounded by blood on both sides \[[@CR83]\] (Figure [21](#Fig21){ref-type="fig"}).Figure 21**Measurements for myocardial T2\* are obtained in the septum.**

T2\* times are frequently reported as relaxation rate, representing the reciprocal of the time constant and calculated as R2\* = 1000/T2\*. The unit of R2\* is Hertz or s^−1^ \[[@CR83]\].

Demographic parameters {#Sec73}
----------------------

It has been shown that T2\* does not correlate with age \[[@CR85]\]. To our knowledge the relationship between other demographic parameters and T2\* has not been assessed yet.

Studies included in this review {#Sec74}
-------------------------------

Generally a T2\* value - measured at the interventricular septum using a multiecho GRE sequence at 1.5T - of \>20 ms is considered normal while the mean myocardial T2\* is around 40 ms \[[@CR81]\].

Examples of studies that used the current multiecho GRE technique with a sample size of \>10 healthy subjects are presented in Table [44](#Tab44){ref-type="table"}.Table 44**References (examples), normal myocardial T2\* valuesFirst author, yearCMR techniqueN, male: femaleAge range (yrs)Mean ± SD (ms)**Kirk, 2010 \[[@CR85]\]GRE, 8 echo times (2.6-16.74 ms)38:2518-7736.3\*Pepe 2006 \[[@CR86]\]GRE, 9 echo times (2.2-20.3)14:6(33 ± 9\*\*)36.4 ± 6.7Anderson, 2001 \[[@CR82]\]GRE, 8 echo times (2.2-20.1 ms)9:626-3952 ± 16GRE = gradient-echo; yrs = years; \* = SD not indicated in original publication; \*\* = mean ± SD, range not mentioned in original publication.

Depending on the risk to develop heart failure as a consequence of myocardial iron overload, a grading system for disease severity has been published (Table [45](#Tab45){ref-type="table"}) \[[@CR87]\].Table 45**Grading of iron overload based on T2\* measurements according to** \[[@CR81],[@CR87]\]**Iron overloadT2\* (ms)**normal\>20iron overload\<20severe iron overload\<10

Regional Measurements and Cardiac Strain {#Sec75}
========================================

CMR acquisition parameters {#Sec76}
--------------------------

A number of imaging methods have been developed to acquire cardiac strain information from CMR including cine CMR, tagged MR, phase-contrast CMR (PC-CMR), velocity encoded CMR, displacement encoding with stimulated echoes (DENSE), and strain-encoding (SENC) \[[@CR88],[@CR89]\]. However, tagged CMR remains a widely validated reproducible tool for strain estimation. The method is used in clinical studies and is considered the reference standard for assessing regional function \[[@CR90],[@CR91]\].

CMR analysis methods {#Sec77}
--------------------

Cardiac strain is a dimensionless measurement of the deformation that occurs in the myocardium. Cardiac strain can be reported as three normal strains (circumferential, radial, and longitudinal) and six shear strains---the angular change between two originally mutually orthogonal line elements, with the more clinically investigated shear strain in the circumferential-longitudinal shear strain (also known as torsion).

There are a number of different methods to quantify strain: registration methods, feature-based tracking methods, deformable models, Gabor Filter Banks, optic flow methods, harmonic phase analysis (HARP) \[[@CR92]\], and local sine wave modeling (SinMod) \[[@CR88]\]. Technical review papers for these methods can be found in the following literature \[[@CR93]-[@CR96]\]. HARP has become one of the most widely used methods for analyzing tagged MR images for cardiac strain, in part due to its large scale use in the Multi-Ethnic Study of Atherosclerosis (MESA) trial \[[@CR92],[@CR97]\].

Strain patterns are reported according to the 16 and 17 segment model of the American College of Echocardiology. Consistent manual tracing of the endocardial and epicardial contours is necessary to reproducible strain results. With tagged CMR, midwall strain is preferred to epicardial and endocardial strain to maximize the amount of tagging data available for strain calculations \[[@CR95],[@CR98]\]. With HARP analysis such as that used in the MESA trial \[[@CR92]\], careful selection of the first harmonic is necessary.

Demographic parameters {#Sec78}
----------------------

With tagged CMR, it has been noted that age is associated with decrease in peak circumferential or longitudinal shortening \[[@CR99],[@CR100]\]. In tagged CMR studies, gender also affects normal values. Cardiac strain values for women are higher than those of men \[[@CR101],[@CR102]\].

Studies included in this review {#Sec79}
-------------------------------

Several studies have presented cohorts of normal individuals for determining normal strain of the left ventricle. For the purpose of this review, only cohorts of 30 or more normal subjects using SPAMM tagging have been included. (Feature tracking methods are being developed for strain, but are being validation in comparison to SPAMM tagging.) Inclusion criteria include a full description of the subject cohort (including the analysis methods used), age and gender of subjects. Table [46](#Tab46){ref-type="table"} represents a summary of publications reporting normal values for midwall strain that fit the criteria \[[@CR89],[@CR90],[@CR98]\].Table 46**Normal values for circumferential, longitudinal und radial strain (maximal strain in %; mean±SD) according to previous publicationsAuthornAge (yrs)Acquis. methodEstimation methodTagged resol.FS (T)basemidapseptantlatinfCircumferential Strain**Moore (2000) \[[@CR98]\]3137 ± 11SPAMMFindTags6 mm1.5−0.19±0.04−0.19±0.05−0.22±0.05−0.17±0.03−0.22±0.05−0.22±0.04−0.18±0.05Cupps (2010) \[[@CR89]\]5032.8±10.6SPAMMfinite element model7 mm1.5−0.19±0.04−0.21±0.04−0.20±0.04−0.18±0.03−0.20±0.04−0.23±0.04−0.19±0.04Del-Canto (2013) \[[@CR90]\]3658.8 ± 11.6SPAMMSinMod7 mm1.5−0.17 ± 0.03−0.20 ± 0.03−0.20 ± 0.03−0.16 ± 0.04−0.20 ± 0.04−0.22 ±0.04−0.18 ± 0.04Venkatesh (2014) \[[@CR103]\]12958.8 ± 9.3SPAMMHARP7 mm1.5−15.1 ± 3.2−18.0 ± 2.2−17.9 ± 2.5**Longitudinal Strain**Moore (2000) \[[@CR98]\]3137 ± 11SPAMMFindTags6 mm1.5−0.15±0.03−0.15±0.03−0.19±0.04−0.16±0.04−0.16±0.04−0.16±0.04−0.16±0.04Cupps (2010) \[[@CR89]\]5032.8±10.6SPAMMfinite element model7 mm1.5−0.13±0.04−0.15±0.03−0.18±0.05−0.16±0.040.15±0.04−0.15±0.04−0.15±0.05**Radial Strain**Moore (2000) \[[@CR98]\]3137 ± 11SPAMMFindTags6 mm1.50.45±0.260.42±0.260.48±0.330.41±0.190.54±0.280.46±0.230.38±0.38Del-Canto (2013) \[[@CR90]\]3658.8 ± 11.6SPAMMSinMod7 mm1.50.13 ± 0.040.09 ± 0.040.12 ± 0.040.09 ±0.050.10 ±0.050.12 ±0.070.14±0.07Venkatesh (2014) \[[@CR103]\]12958.8 ± 9.3SPAMMHARP7 mm1.527.4 ± 5.624.8 ± 5.323.4 ± 6.7yrs = years; Acquis. = Acquisition; resol. = resolution; FS = field strength; T = Tesla; SPAMM = spatial modulation of the magnetization; mid = mid cavity; ap = apical level; sept = septal; ant = anterior; lat = lateral; inf = inferior.

With tagged CMR, normal midwall circumferential \[[@CR89],[@CR92],[@CR93],[@CR98],[@CR101],[@CR104]\] and longitudinal \[[@CR89],[@CR96],[@CR98],[@CR104]\] strain values are relatively comparable between studies. For radiation strain, moderate differences between published results exist for reference values, probably due to low tag density by most methods in the radial direction \[[@CR90],[@CR96]-[@CR98],[@CR101],[@CR104]\].

Conclusions {#Sec80}
===========

Cardiovascular magnetic resonance enables quantification of various functional and morphological parameters of the cardiovascular system. This review lists reference values and their influencing factors of these parameters based on current CMR techniques and sequences.

Advantages of a quantitative evaluation are a better differentiation between pathology and normal conditions, grading of pathologies, monitoring changes under therapy, and evaluating prognosis and the possibility of comparing different groups of patients and normal subjects.
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